Investing.com - Wolfe Research upgraded Immunovant (NASDAQ:IMVT) from Peerperform to Outperform with a price target of $50.00, citing improved investor perception of the company’s Graves’ disease ...

A doctor explains 19 visible signs of hyperthyroidism, also known as Graves disease, helping identify early physical changes linked to overactive thyroid function. Mike Johnson gives update on Jan. 6 ...

A woman from California has an unusual practice. She scours cemeteries to find and cook recipes left by the deceased — and etched on their tombstones. Over the last five years, Rosie Grant, a ...

BASRA, IRAQ, January 6, 2026 /EINPresswire.com/ — Markers and Headstones, a U.S.-based manufacturer of memorial markers, has contributed to a meaningful restoration ...

CAMBRIDGE, Mass., Jan. 11, 2026 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM) today announced continued progress toward its mission to build a sustainable, predictable model for the ...

Dorian Graves is one of the handful of characters you'll need to speak with while playing Devil Hunter. Unfortunately, the title of the character is usually on the screen, rather than their actual ...

Ended 2025 with Estimated $1.25 Billion in Cash, Cash Equivalents and Marketable Securities; Projected Operating Runway Extension into 2029 Supports Anticipated risto-cel Launch and Execution of ...

With the municipal corporation elections nearing, citizen groups and ALMs (Advanced Locality Managements) have begun placing their demands before political parties and candidates. The Gulmohar Area ...

In a first for the U.S., Utah is letting artificial intelligence — not a doctor — renew certain medical prescriptions. No human involved. The state has launched a pilot program with health-tech ...

Alignment Reached with U.S. FDA on Potential Accelerated Approval Pathway for BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) Based on Biomarker Endpoints U.S. Biologics Licensing Application (BLA) ...